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Background: Notch signaling, a critical pathway for tissue development, contributes to tumorigenesis in many
tissues; however, the roles of Notch signaling in Intrahepatic Cholangiocarcinoma (ICC) remains unclear. In this
study, we evaluated the expression and effects of Notch1 on cell migration in ICC.
Methods: Multiple cellular and molecular approaches were performed including gene transfection, siRNA
transfection, RT-PCR, Western blotting, Rac activation assays and immunofluorescence.
Results: We found that Notch1 was up-regulated in ICC tissues and cell lines. The exogenous expression of Notch1
in glioma cells increased their migratory and invasive capacity. Similarly, the suppression of Notch1 expression
inactivated Rac1 and inhibited ICC cell migration. Notch1 over expression induced an Epithelial-to-mesenchymal
transition (EMT) phenotype that included enhanced expression of α-SMA and Vimentin, loss of E-cadherin
expression, morphological changes and cytoskeletal reorganization in ICC cells.
Conclusion: Notch1 may induce a migratory effect in ICC by causing an epithelial-mesenchymal transition and
activating Rac1 and could serve as a novel diagnostic and therapeutic target in patients with ICC.
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Intrahepatic Cholangiocarcinoma (ICC) is the second
most common subtype of primary hepatobiliary cancer
[1,2]. Significant geographic variation exists in the inci-
dence of cholangiocarcinoma, with the highest incidence
in East Asia. Despite advances in surgical and medical
therapy, the survival rate is still very poor. The primary
reason for the poor prognosis is metastasis, which pre-
cludes curative surgical resection. Prognosis is dependent
on the presence of free margins in resected tissues and the
absence of lymph node metastasis [3]. Increased cell inva-
sion and migration are key phenotypic advantages of ma-
lignant cells that favor metastasis. Recent studies have
shown that tumor metastasis can be regarded as a reacti-
vation of at least some aspects of the embryonic program
of the EMT. During EMT, epithelial cells undergo ex-
tensive alterations in gene expression to lose apical/
basolateral polarity, sever intercellular adhesive junctions,* Correspondence: jpli3s@medmail.com.cn
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reproduction in any medium, provided the ordegrade basement membrane components, and become
individual, non-polarized, motile and invasive mesenchy-
mal cells [4].
Notch signaling is an ancient cell signaling system that
regulates cell fate specification, stem cell maintenance,
and the initiation of differentiation in embryonic and
postnatal tissues. Four Notch receptors isoforms, namely
Notch1, Notch2, Notch3, and Notch4, and five ligands,
Jagged 1 and Jagged 2 belonging to the Serrate family
and Delta 1, Delta 3, and Delta-like 4 belonging to the
Delta family, have been identified in mammals. The
pathway is activated through the interaction of a Notch
receptor with a Jagged or Delta-like ligand, leading to
proteolytic cleavages of the Notch receptor at two dis-
tinct sites. This cleavage releases the Notch intracellular
domain (ICN), allowing it to enter the nucleus and func-
tion as a transcriptional activator. Importantly, the sec-
ond cleavage is mediated by the gamma secretase
complex, and effective inhibition of Notch activation can
be achieved by pharmacological inhibition of this pro-
teolytic activity. Notch signaling is known to regulate
many cellular processes, including cell proliferation,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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expression has been reported to be up-regulated in many
human malignancies [5]. Interestingly, the function of
Notch signaling in tumorigenesis has been shown to be
either oncogenic or anti-proliferative [6-8]. In some
tumor types, including skin cancer, human hepatocellu-
lar carcinoma and small cell lung cancer, Notch signal-
ing has been shown to play anti-tumor roles rather than
oncogenic roles [7]. However, most studies have shown
that Notch has oncogenic effects in many human carcin-
omas. In cervical, lung, colon, head and neck, renal car-
cinoma, acute myeloid leukemia, Hodgkin and large-cell
lymphomas and pancreatic cancer [9,10], Notch is un-
doubtedly oncogenic. Moreover, high-level expression of
Notch-1 and its ligand Jagged-1 is associated with poor
prognosis in breast cancer, bladder cancer, leukemia, and
prostate cancer [11-13]. However, the roles of Notch sig-
naling in intrahepatic cholangiocarcinoma have not yet
been characterized. Thus, in the present study, we ex-
plored the role of Notch1 expression, especially in rela-
tion to migration, in ICC.
Methods
Intrahepatic cholangiocarcinoma patient samples
Intrahepatic cholangiocarcinoma tissues were collected
from five patients who underwent hepatectomy in our
Hospital. None of the patients had received preoperative
chemotherapy or radiotherapy. The five cholangiocar-
cinoma patients included 3 cases with infiltration of the
surrounding tissue (such as the liver, portal vein, nerve,
and pancreas) and 2 cases with regional lymph node
metastasis. The specimens were obtained with written
informed consent from all patients. The study was ap-
proved by the Committees for Ethical Review of Re-
search involving Human Subjects in our Hospital.
Cell culture
The human normal biliary epithelial cells established
from histologically normal liver tissues obtained from
five patients who underwent liver transection for
metastatic tumors were gifts from Dr. Ludwik K
Trejdosiewicz (University of Leeds, UK) [14]. The hu-
man cholangiocarcinoma cell lines QBC939, RBE, and
ICC-9810 were obtained from ATCC and cultured in
Ham’s F12 Medium supplemented with 10% FBS at 37°C
in a humidified chamber containing 5% CO2.
Antibodies
Antibodies against Notch-1, E-cadherin, Vimentin, F-actin
and α-SMA were purchased from Santa Cruz Biotech-
nology, Inc. (Santa Cruz, CA, USA). The GAPDH anti-
body was purchased from Sigma-Aldrich (St. Louis,
MO, USA).RNA extraction and reverse transcription-PCR
Total RNA was extracted using TRIzol reagent (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s proto-
col. cDNA was synthesized using TaqMan RT reagents
(Applied Biosystems) following the manufacturer’s ins-
tructions. The primers for Notch1 and the glyceraldehyde
3-phosphate dehydrogenase (GAPDH) control were syn-
thesized by Invitrogen (Carlsbad, CA, USA). The upstream
Notch1 primer was 5′-GCAAGAAGAAGCGGAGAG-3′,
and the downstream primer was 5′- AGCTGGCACCC
TGATAGATG -3′; the Notch1 PCR product length was
423 bp. The upstream control GAPDH primer was 5′-
AGATCCACAACGGATACATT-3′, and the downstream
primer was 5′-TCCCTCAAGATTGTCAGCAA-3′; the
GAPDH PCR product length was 308 bp. The PCR condi-
tions were as follows: predenaturing at 94°C for 2 min, de-
naturing at 94°C for 30 s, reannealing at 53°C for 45 s, and
elongation at 72°C for 30 s, for 30 cycles; and final elong-
ation at 72°C for 10 min. The PCR products underwent
1.5% agarose gel electrophoresis.
Western blot analysis
Protein was quantified using the Bradford assay (Bio-
Rad, Hercules, CA, USA), and equal amounts of protein
were separated on SDS-polyacrylamide gels and trans-
ferred onto nitrocellulose membranes (Amersham Bio-
sciences, Piscataway, NJ, USA). After blocking in 5%
skim milk for 1 h at room temperature, the membranes
were incubated with the indicated primary antibody at 4°C
overnight, followed by a horseradish peroxidase-conjugated
secondary antibody. The proteins were detected by che-
miluminescence (Amersham Biosciences, Piscataway, NJ,
USA). The Western blot data were quantified by measuring
the intensity of the hybridization signals using an image
analysis program (Fluor-ChemTM 8900, Alpha Inotech).
Plasmid constructs and siRNA transfection
The full-length Notch1 cDNA was amplified and
cloned into the pReciever M68 expression vector
(FulenGen, Guangzhou, China). The expression plas-
mids were transfected into cells using Lipofectamine
2000 (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s instructions.
Oligonucleotide siRNA duplexes were synthesized by
Shanghai Gene Pharma (Shanghai, China). The following
siRNA sequences for Notch1 were used: 5′- UGGCGG
GAAGUGUGAAGCG-3′ and 5′- CGCUUCACACUUC
CCGCCA-3′. The siRNAs were transfected into ICC-
9810 cells with Lipofectamine 2000 (Invitrogen, Carlsbad,
USA) according to manufacturer’s instructions.
BrdU incorporation analysis
Ten micrograms per milliliter of BrdU were added to
the culture medium for 24 h. The cells were fixed with
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HCl for 45 min and 0.1 ml sodium tetraborate for
15 min at room temperature. The cells were then incu-
bated with a mouse monoclonal anti-BrdU antibody
overnight at 4°C and incubated with fluoresce in
isothiocyanate-conjugated goat anti-mouse IgG for 1 h
at room temperature. Hoechst 33342 was used to label
nuclei.
Rac activation assay
Rac1 intracellular activity was examined using Rac1 acti-
vation assay kits (Upstate Biotechnology, Lake Placid,
NY, USA) according to the manufacturer’s protocols.
Briefly, cells were lysed with Mg2+ lis buffer. After clari-
fying the cell lysates with glutathione agarose and quan-
tifying the protein concentrations, aliquots with equal
amounts of proteins were incubated with the Rac assay
reagent (PAK-1 PBD, agarose) at 4°C for 1 h, using the
GTPgS-pretreated lysates as positive controls. The pre-
cipitated GTP-bound Rac1 was then eluted in Laemmli
reducing sample buffer, resolved by 12% SDS-PAGE, and
immunoblotted with a monoclonal anti-Rac1 antibody.
Five percent of the cell lysate was resolved by 10% SDS-
PAGE and immunoblotted with a Rac1 antibody to
measure the total amount of Rac1.
Immunocytochemistry
Immunohistochemical staining was performed on 4-μm
paraffin-embedded kidney sections. Antigen retrieval
was performed by microwave treatment. The sections
were exposed to 3% H2O2 for 20 min, blocked with 10%
sheep serum in PBS at 37°C for 40 min, then incubated
with the indicated antibodies at 4°C overnight. After
rinsing three times with PBS, the sections were incu-
bated with ChemMate™ EnVision/HRP Rabbit/Mouse
secondary antibody (Dako, Copenhagen, Denmark) for
1 h. The degree of immunostaining was reviewed and in-
dependently scored by two observers based on the pro-
portion of positively stained tumor cells and intensity of
staining.
Migration assay
Cells (1 × 105) were suspended in 200 μl of serum-free
DMEM medium and seeded on the upper side of the in-
vasion chamber (Millipore, Billerica, USA). The lower side
of the chamber was filled with DMEM supplemented with
10% fetal bovine serum. After incubation at 37°C for 18 h,
cells that had penetrated through the chamber were fixed
with methanol for 15 min at room temperature and
stained with 0.1% crystal violet for another 15 min. The
upper surface of the chamber was carefully wiped with a
cotton-tipped applicator. Cells that had passed through
the pores were counted in five non-overlapping fields (×40
magnification) and photographed.Cell morphology examination and immunofluorescence
Cell morphology was monitored on a phase contrast
microscope equipped with a video camera. Cells grown
on glass coverslips were fixed with 3.7% formaldehyde
solution in PBS for 10 min at room temperature. Fol-
lowing three extensive washes with PBS, the cells were
permeabilized in PBS containing 0.1% Triton X-100 for
3 min and blocked with PBS containing 5% BSA for 1 h
at room temperature. The cells were incubated over-
night at 4°C with primary antibodies diluted in PBS
containing 3% BSA, followed by incubation with Alexa
Fluor 488-conjugated goat anti–rabbit secondary anti-
body (1:1000; Molecular Probes, Eugene, OR, USA) for
1 h at room temperature for detection. Actin filaments
were visualized by staining the cells with Alexa Fluor
633-conjugated Phalloidin (1:1000; Molecular Probes,
Eugene, OR, USA) for 1 h at room temperature. To
identify nuclei, the cells were counterstained with DAPI
(Invitrogen, Carlsbad, CA, USA) for 3 min. The cover-
slips were mounted in fixation medium (Biomeda,
Foster City, CA, USA). Images were collected and ana-
lyzed using the Zeiss LSM 510 Confocal Imaging Sys-
tem (Zeiss, Germany).
Statistical analysis
The statistical analyses were performed using SPSS 13.0
statistical software (Chicago, IL, USA). Significant differ-
ences between two groups were determined by Student’s
t-test. P < 0.05 was considered statistically significant.
The results are expressed as the mean ± SD from at least
three experiments.
Results
Notch1 was up-regulated in ICC tissues and cell lines
Abnormally high Notch1 expression has been impli-
cated in many malignancies, but the pathological func-
tion of Notch1 in ICC has not been well defined.
Therefore, reverse transcription-PCR and Western blot-
ting analyses were performed on paired samples of ICC
tissue and noncancerous tissue adjacent to the cancer
lesion isolated from the same patient. Notch1 was found
to be over expressed at both the mRNA and protein
levels in all five ICC samples examined compared to ad-
jacent tissue from the same patient (Figure 1A). Inter-
estingly, among the five cholangiocarcinoma patients,
patients No. 1, 2, and 3 displayed infiltration of the sur-
rounding tissue (invasion of the liver, portal vein, nerve,
and pancreas), and patients No. 2 and 3 displayed re-
gional lymph node metastases.
We further investigated Notch1 protein expression in
ICC specimens and normal control liver tissues using
immunohistochemical analysis. Notch1 staining was
primarily localized to the cell membrane and cytoplasm,
suggesting that the protein was active. No significant
N1        T1         N2        T2          N3         T3        N4          T4         N5        T5
Notch1    423 bp
GAPDH 308 bp
A
ICN       120 kD
GAPDH  37 kD
Normal
ICN        120 kD




Figure 1 Notch1 is up-regulated in ICC tissues and ICC cell lines. (A) The expression of ICN (the intracellular domain of Notch1) is elevated in
primary ICC tumors (T) compared with ICC tumor-adjacent tissues (N) examined by Western blotting. (B) The expression of Notch1 mRNA in each
of the primary ICC tumor (T) and ICC noncancerous tissue (N) pairs from the same patient by reverse transcription-PCR. β-actin was used as a
loading control. (C) The expression of ICN protein is elevated in ICC cell lines.
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only weak staining was observed in the cell membrane
and cytoplasm of a few cells (Figure 1B).
We next examined the expression of Notch1 in nor-
mal and ICC cells. As shown in Figure 1C, all cancer cell
lines expressed high levels of Notch1 compared with
normal biliary epithelial cells. The aberrant Notch1 ex-
pression in both ICC tissues and ICC cells suggests that
increased Notch1 expression might be associated with
tumor progression.
We also examined the expression of other Notch re-
ceptors (Notch2, Notch3, and Notch4) in ICC tissue
and noncancerous tissue adjacent to the cancer lesions.
As shown in Figure 2, Notch1 was found to be
overexpressed in all five ICC cancer samples examined
compared to normal adjacent tissue from the samepatients, but the other receptors were not differentially
expressed.Notch1 over expression activated Rac1 and promoted ICC
cell migration
Exogenous expression of Notch1 in glioma cells has
been shown to increase their migratory and invasive
capacity [15]. To explore the function of Notch1 upre-
gulation in ICC, exogenous Notch1 was transfected into
ICC-9810 cells. We first examined Rac1 activity. As
shown in Figures 3A, 3B, and 3D, over expression of
Notch1 resulted in a dramatic increase in the GTP-
loaded Rac1 compared with empty vector-transfected
cells. Given the important role of Rac1 activation in cell
migration, we next examined the effect of Notch1 over
ICN        80  kD
GAPDH  37 kD
N1       T1        N2      T2        N3      T3        N4       T4       N5      T5
Notch1   120 kD
Notch2   265 kD
Notch3   240 kD
Notch4   210 kD
Figure 2 The expression of other Notch receptors (Notch2, Notch3, and Notch4) in ICC tissue and noncancerous tissue adjacent to the
cancer lesions. Notch1 was found to be overexpressed in all five ICC cancer samples examined compared to normal adjacent tissue from the
same patients, but the other receptors were not differentially expressed.
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system (Figure 3C).
Notch1 knockdown inactivated Rac1 and inhibited ICC
cell migration
In reciprocal experiments, we examined whether knocking
down endogenous Notch1 would inhibit Rac1 activity and
cell migration using Notch1 siRNA. The efficiency of the
Notch1 siRNA was examined by Western blot (Figure 4A).
Compared with scramble siRNA-transfected cells, the
GTP-Rac1 level was dramatically decreased in Notch1
siRNA-transfected cells (Figure 4B). Similarly, suppression
of Notch1 expression inhibited cell migration compared
with scramble siRNA-transfected cells (Figure 4C). Knock-
down of endogenous Notch1 inhibits Rac1 activity and cell
migration. ICC-9810 cells were transfected with Notch1
siRNA or scramble siRNA (Control) (Figure 4D).
Notch1 expression did not stimulate ICC cancer cell
proliferation
To exclude the possibility that the increased cell migra-
tion was due to Rac1 activation, not cell proliferation,
we over expressed and knocked down Notch1 in ICC-
9810 cells, which express moderate levels of Notch1. As
shown in Figure 5, BrdU incorporation analysis indicated
that Notch1 expression did not affect cell proliferation.
Notch1 over expression induced an EMT phenotype in
ICC cancer cells
To demonstrate that the ICN is sensitive to gamma-
secretase inhibitor, we performed western blot analysis
to evaluate the ICN expression in ICC-9810 cells treated
with 1 μmol/L GSI. This analysis confirmed that ICN
was induced at the protein level within 24 hours of ex-
posure to the GSI but was not induced by the DMSO
control (Figure 6).Notch activation has been shown to induce an epithelial
to mesenchymal transition in breast cancer [16] Given
that Notch1 expression was associated with ICC metasta-
sis, we further investigated whether a link exists between
Notch1 expression and the EMT phenomenon in ICC. Ex-
ogenous Notch1 was transfected into ICC-9810 cells that
express moderate levels of Notch1. Increased Notch1 ex-
pression was accompanied by enhanced expression of α-
SMA and Vimentin and loss of E-cadherin expression,
which are hallmarks of EMT (Figure 6A). An examination
of cell morphology and immunofluorescence indicated
that Notch1 over expression resulted in morphological
changes and cytoskeletal reorganization in ICC-9810 cells
(Figure 6).
Discussion
Notch genes encode large transmembrane proteins
that act as receptors for the Delta, Serrate, Lag-2 (DSL)
family of ligands [17]. Four different Notch proteins
and the following five known ligands exist in mam-
mals: Delta-like 1, Delta-like 3, Delta-like 4, Jagged 1
and Jagged 2 [18-22]. Notch signaling plays multiple
roles in development and tissue homeostasis, and these
roles can be subverted during oncogenic transform-
ation. Despite the wealth of data suggesting a role for
Notch in solid tumors, little evidence exists to support
a causative role for Notch in tumor initiation in human
solid cancers. Indeed, unlike in T-ALL, genetic alter-
ations in Notch genes have not been identified in solid
tumors. However, Notch signaling appears to be cru-
cial in many solid tumors, including cancers of the
breast, colon, pancreas, prostate and central nervous
system [23]. Interestingly, Notch signaling also seems
to play a contradictory tumor suppressor role in mouse
keratinocytes, pancreatic and hepatocellular carcin-
oma, and small-cell lung cancer [24]. Taken together,
these observations indicate that Notch exerts its effects
Empty vector Notch1
1              2              3
ICN           120 kD

































Figure 3 Overexpression of Notch1 activated Rac1 and promoted cell migration. (A) ICC-9810 cells were transfected with empty vector or
Notch1, respectively. 48 h after transfection, the amount of active GTP-bound Rac1 was determined by antibodies specific for Rac1. (B) For
Boyden chamber motility assay, cells were seeded onto the filter in the upper compartment of the chamber and incubated for 18 h. Cells passing
through the pores were counted in five non-overlapping × 40 fields and photographed. *P < 0.05 vs vector transfected cells. (C) The activity of
Rac1 after transfection 48 h. (D) The number of cells penetrated through the chamber in Migration assay. Notch1 transfected cells high expressed
Notch1 compared with the cells in the control group. The number of cells penetrated through the chamber increased obviously. To prove that
the increase of cells penetrated through the chamber was caused by the ability of cell migration, rather than cell proliferation, we also employed
BrdU incorporation analysis to assay for cell proliferation. *P < 0.05 vs vector transfected cells. Data are expressed as mean ± SD of three
independent experiments.
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Figure 4 Knockdown of endogenous Notch1 inhibits Rac1 activity and cell migration. ICC-9810 cells were transfected with Notch1 siRNA
or scramble siRNA (Control) (A). The ICN is sensitive to gamma-secretase inhibitor. Western blot analysis was employed to the ICN expression of
ICC-9810 cells treatmented with 1 μmol/L of GSI. The results confirmed that ICN was induced at the protein level within 24 hours of exposure to
the GSI but not by the DMSO control. Forty-eight hours after transfection, cell migration (B and C) and the Rac1 activity (D) were examined.
*P < 0.05 vs. scramble siRNA-transfected cells. The data are expressed as the mean ± SD of three independent experiments.
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pathway. Moreover, the cellular interpretation and out-
come of aberrant Notch activity is highly dependent on
contextual cues, such as interactions with the tumormicroenvironment and crosstalk with other signaling
pathways.
Intrahepatic cholangiocarcinoma is the second most
prevalent intrahepatic primary cancer and has poor
Untransfected
Scramble 
siRNA     
Notch1 
transfected
Untransfected Scramble siRNA     Notch1 transfected
Figure 5 Cell growth proliferation was assessed by BrdU incorporation analysis. BrdU-positive cells, stained green. The number of positive
cells reflects the ability of proliferation. However, no change of the number of BrdU -positive cells was observed in the Notch1 down- expression
group or Notch1 high expression group compared to the control group. The results demonstrated that Notch1 down-regulating expression or
high expression did not have any effect on cell proliferation.
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rapid tumor growth and the tendency to invade adjacent
organs and metastasize [25].
Mounting evidence has demonstrated that EMT is as-
sociated with the invasive and migratory ability of cancer
cells, conferring enhanced metastatic properties to these
cells [26-28]. Increased expression of Notch1 has been
shown to promote EMT in glioma; however, the role of
Notch1 in ICC remains unclear.
In the present study, we found that Notch1 mRNA
and ICN (the intracellular domain of Notch1) expression
is higher in ICC tissue than in noncancerous tissue adja-
cent to the cancer lesions, and all cancer cell lines
expressed high levels of ICN compared with normal bil-
iary epithelial cells. Taken together, aberrant Notch1 ex-
pression in both ICC tissues and ICC cells suggests that
increased Notch1 expression might be associated with
tumor progression.
To elucidate the effects of Notch1 expression in ICC
cells, separate over expression and knockdown experi-
ments were conducted in ICC-9810 cells. Notch1 cDNA
was introduced into ICC-9810 cells, and Notch1 protein
expression was successfully induced. Notch1 over expres-
sion promoted migration and Rac1 activation in these
cells. In contrast, the down-regulation of Notch1 inhibited
the migration of ICC-9810 cells and resulted in dramatic
decreases in Rac1 activity compared to control cells. Sub-
stantial evidence has indicated that increased Notch1
expression is accompanied by enhanced expression ofα-SMA and Vimentin and loss of E-cadherin expres-
sion, which are hallmarks of EMT.
The Rho-like GTPase Rac1 is involved in migration
and adhesion by modulating the actin cytoskeleton.
Rac1 acts as a molecular switch, cycling between an ac-
tive GTP-bound state and an inactive GDP-bound
state, which is controlled by GEF. Rac1 is preferentially
activated at the leading edge of migrating cells where it
induces the formation of actin-rich lamellipodia pro-
trusions that are thought to be a key driving force for
membrane extension and cell movement. Rac1 is also
an important regulator of the actin cytoskeletal dy-
namics that modulate cell migration and invasion [29].
Elevated levels of GTP-Rac1 have been shown to cor-
relate with tumor metastasis and vascular endothelial
growth factor (VEGF) expression [30]. Despite the im-
portance of the upstream signaling mechanisms that
facilitate Rac activation, the identity of these mecha-
nisms in ICC remains unknown. In the present study,
we demonstrated for the first time that the protein
level of Notch1 is elevated in ICC tissues and that
Notch1 over expression promotes migration and Rac1
activation in human ICC-9810 cells. By examining cell
morphology and immunofluorescence, we found that
Notch1 over expression results in morphological changes
and alterations in the F-actin cytoskeleton in ICC-9810
cells (Figure 4). These results suggest that upregulation
of Notch1 could promote ICC cell migration and inva-










Untransfected                               Notch1 transfected
Empty vector
NucleusNotch1 F-actin Merge





Figure 6 Notch1 overexpression induces an EMT phenotype in ICC-9810 cells. (A) Increased Notch1 expression was accompanied by
enhanced expression of α-SMA and Vimentin and loss of E-cadherin expression, which are hallmarks of EMT. (B) Overexpression of Notch1 results
in morphological changes in ICC-9810 cells. Photographs were taken using a Nikon microscope (phase contrast). Original magnification × 400.
(C and D) ICC-9810 cells were infected with Notch1 or vector for 36 h before fixation and processing for immunofluorescence staining. Actin filaments
were visualized by staining with Alexa Fluor 633-Phalloidin (red). Notch1 was visualized by staining with an anti-Notch1 antibody followed by Alexa Fluor
488-conjugated anti-rabbit IgG (green). Nuclei were stained with DAPI (blue). Images were taken by confocal microscopy. Original magnification × 630.
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effects of γ-secretase on Notch1, resulting in decreased
production of the Notch1 intracellular domain and a
slight decrease in the shedding of the ectodomain form of
Notch1 [31]. We have shown that down-regulation of
Notch1 results in a dramatic decrease in Rac1 activity,
suggesting that a mechanism exists to determine whether
Rac1 or Notch1 is the preferred substrate for γ-secretase;
however, this mechanism requires further elucidation.
Conclusions
In conclusion, we have shown here that Notch1 ex-
pression is upregulated in clinical ICC specimens andpromotes tumor migration, indicating that Notch1
may be involved in ICC carcinogenesis and progres-
sion. These findings suggest that Notch1 could serve
as a novel diagnostic and therapeutic target in patients
with ICC and thereby establish the potential for
targeting Notch signaling as an approach to inhibit
tumor metastasis.
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